Relation of-55CT polymorphism of UCP3 gene with weight loss and metabolic changes after a high monounsaturated fat diet in obese non diabetic patients

被引:0
|
作者
De Luis, D. A. [1 ]
Aller, R.
Izaola, O.
De La Fuente, B.
Conde, R.
Eiros Bouza, J. M.
机构
[1] Univ Valladolid, Hosp Rio Hortega, Sch Med, Inst Endocrinol & Nutr, Valladolid, Spain
关键词
55CT polymorphism of UCP3 gene; Monounsaturated fatty acids; Obesity; HUMAN UNCOUPLING PROTEIN-3; BODY-MASS INDEX; SKELETAL-MUSCLE; ASSOCIATION; ADIPONECTIN; SENSITIVITY; PHENOTYPES; INSULIN; GLUCOSE; LINKAGE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AIMS: The aim of our study was to investigate the influence of -55CT polymorphism of UCP3 gene on metabolic response, weight loss and serum adipokine levels to a high monounsaturated fat hypocaloric diet in obese patients. PATIENTS AND METHODS: A sample of 128 obese patients was analyzed in a prospective way during 3 months. RESULTS: Eighty eight patients (21 males/67 females) (68.8%) had the genotype 55CC (wild genotype group) and 40 patients (8 males/32 females) (31.3%) 55CT (mutant genotype group). In wild genotype group, BMI (-1.6 +/- 1.3 kg/m(2)), weight (-4.3 +/- 3.7 kg), fat mass (-3.5 +/- 3.3 kg), waist circumference (-5.1 +/- 2.9 cm), total cholesterol (-7.2 +/- 10.6 mg/dl), LDL cholesterol (5.3 +/- 12.8 mg/dl) and leptin (-4.+/- 10.1 ng/ml) decreased. In mutant genotype group, BMI (1.3 +/- 2.2 kg/m(2)), weight (-3.0 +/- 1.4 kg), fat mass (-2.5 +/- 1.1 kg), waist circumference (-2.8 +/- 3.1 cm) and leptin (-5.8 +/- 10.7 decreased. CONCLUSIONS: In patients with -55CC UCP3 genotype, a high mono-unsaturated hypocaloric diet reduced BMI, weight, waist circumference, waist to hip ratio, fat mass, LDL-cholesterol, total cholesterol and leptin levels. Carriers of T allele had a different response than -55CC patients, with a significant decrease of the same antropometric parameters, but lower than in the wild genotype group, and without significant changes in cholesterol levels.
引用
收藏
页码:2810 / 2815
页数:6
相关论文
共 36 条
  • [31] Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase ( FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients
    de Luis, D. A.
    Izaola, O.
    Aller, R.
    de la Fuente, B.
    Pacheco, D.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (11) : 965 - 969
  • [32] Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients
    D. A. de Luis
    O. Izaola
    R. Aller
    B. de La Fuente
    D. Pacheco
    Journal of Endocrinological Investigation, 2013, 36 : 965 - 969
  • [33] Effect of Lys656Asn Polymorphism of Leptin Receptor Gene on Cardiovascular Risk Factors and Serum Adipokine Levels after a High Polyunsaturated Fat Diet in Obese Patients
    de Luis, D. A.
    Aller, R.
    Izaola, O.
    Gonzalez Sagrado, M.
    Conde, R.
    de la Fuente, B.
    Primo, D.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2015, 29 (06) : 432 - 436
  • [34] Effect of Fatty Acid-Binding Protein 2 Ala54Thr Genotype on Weight Loss and Cardiovascular Risk Factors After a High-Polyunsaturated Fat Diet in Obese Patients
    de Luis, Daniel
    Aller, Rocio
    Izaola, Olatz
    Gonzalez Sagrado, Manuel
    de la Fuente, Beatriz
    Conde, Rosa
    Primo, David
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (08) : 1194 - 1198
  • [35] Effects of Trp64Arg mutation in the beta(3)-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients
    Sakane, N
    Yoshida, T
    Umekawa, T
    Kogure, A
    Takakura, Y
    Kondo, M
    DIABETES CARE, 1997, 20 (12) : 1887 - 1890
  • [36] Metformin 2550 MG per day in non-diabetic obese patients on a dietary and exercise programme induce greater weight loss without a similar change in metabolic and blood pressure profiles after six months of treatment
    Silva-Nunes, JA
    Gardete-Correia, LMR
    Nunes-Corrêa, JCC
    DIABETOLOGIA, 2002, 45 : A220 - A220